Caption Management, LLC Heron Therapeutics, Inc. Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $83,950 - $229,585	-36,500 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.63 - $9.94 $1.45 Million - $3.11 Million	-312,610 Reduced 89.54%	36,500 $209,000
Q4 2021 Feb 11, 2022	BUY	$8.35 - $12.6 $2.92 Million - $4.4 Million	349,110 New	349,110 $3.19 Million
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $490,990 - $683,760	-37,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$14.49 - $20.72 $657,846 - $940,688	-45,400 Reduced 55.1%	37,000 $600,000
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $842,952 - $2.02 Million	82,400 New	82,400 $967,000
Q4 2019 Feb 13, 2020	SELL	$17.42 - $26.61 $1.37 Million - $2.09 Million	-78,650 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $877,714 - $1.15 Million	53,650 Added 214.6%	78,650 $1.46 Million
Q2 2019 Aug 13, 2019	SELL	$16.93 - $26.22 $206,546 - $319,884	-12,200 Reduced 32.8%	25,000 $465,000
Q1 2019 May 14, 2019	BUY	$23.15 - $28.34 $861,180 - $1.05 Million	37,200 New	37,200 $909,000

181

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $141M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.